ASBISC ENTERPRISES PLC
NOTES TO THE CONSOLIDATED AND SEPARATE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
(in thousands of US$)
50
11. Investment in subsidiary companies
The Company
2022
2021
US$
US$
Cost
At 1 January
23,623
19,501
Increase in investments (i), (ii), (iii), (iv), (v)
3,302
3,933
(Decrease)/increase in fair value of financial guarantees to
subsidiaries (xii)
(272)
189
At 31 December
26,653
23,623
Accumulated impairment
At 1 January
(5,412)
(3,055)
Impairment charge for the year (vii)
-
(2,357)
At 31 December
(5,412)
(5,412)
Carrying amount of investment in subsidiary companies
21,241
18,211
(i) In August 2022, the Company acquired 100% shares of the company Entoliva Ltd (Cyprus) and holds 100% in
this subsidiary, being the equal to share capital of US$ 10. In November 2022, the Company acquired the 100%
shares of the company ASBIS HELLAS SINGLE MEMBER S.A. (Greece) and holds 100% in this subsidiary, being
equal to share capital of US$ 103.
(ii) In April 2022 and November 2022, the Company increased its investment in its wholly owned subsidiary ASBIS
POLAND SP. Z.O.O (Poland) for the amount of US$ 479 and US$ 861 respectively. In April 2022, the Company
increase its investment in its 65.85% owned subsidiary ASBC MMC (Uzbekistan) for the amount of US$ 329. In
December 2022, the Company increased its investment in its wholly owned subsidiary E.M. EURO-MALL LTD for
the amount of US$ 1,520.
(iii) In February 2021, the Company acquired the 100% shareholding of ASBIS CA LLC (Uzbekistan) and holds 100%
in this subsidiary, being equal to share capital of US$ 50. In August 2021, the Company acquired the 100%
shareholding of ASBC LLC (Armenia) and holds 100% in this subsidiary, being equal to share capital of US$ 245.
In December 2021, the Company acquired the 100% shareholding of ASBC Entity OOO (Uzbekistan) and holds
100% in this subsidiary, being equal to share capital of US$ 51.
(iv) In March 2021, the Company acquired the remaining 50% shareholding of Breezy Trade-In Ltd (Cyprus) for the
total consideration of US$ 31 and in October 2021, disposed 20% shareholding for the total consideration of
US$ 80.
(v) In April 2021, the Company increased its investment in its wholly owned subsidiary ASBIS IT Solutions Hungary
Kft (Hungary) for the amount of US$ 199. In May 2021, the Company increased its investment in its wholly
owned subsidiary ASBC F.P.U.E. (Belarus) for the amount of US$ 142. In July 2021, the Company increased its
investment in its 70% owned subsidiary I.O.N Clinical Trading Ltd (Cyprus) for the amount of US$ 240. In
November 2021, the Company increased its investment in its wholly owned subsidiary ASBIS POLAND SP. Z.O.O
(Poland) for the amount of US$ 216.
(vi) In March 2021, the Company increased its investment in its wholly owned subsidiary ASBIS PL SP. Z O.O.
(Poland) for the amount of US$ 2,357 and impaired the full amount.
(vii) During 2022, the Company decreased its financial guarantees provided to subsidiaries for the amount of US$
272 (2021: increase of US$ 189).
All subsidiaries are involved in the trading and distribution of computer hardware and software apart from Entoliva Ltd
which is involved in land development.
The Company periodically evaluates the recoverability of investments in subsidiaries whenever indicators of impairment
are present. Indicators of impairment include such items as declines in revenues, earnings or cash flows or material
adverse changes in the economic or political stability of a particular country, which may indicate that the carrying
amount of an asset is not recoverable. If facts and circumstances indicate that investment in subsidiaries may be
impaired, the estimated future discounted cash flows associated with these subsidiaries would be compared to their
carrying amounts to determine if a write-down to fair value is necessary.